|
Volumn 28, Issue 1, 2003, Pages 39-51
|
The role of somatostatin analogues in the treatment of hypophyseal adenomas;Ruolo degli analoghi della somatostatina nel trattamento degli adenomi ipofisari.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOPEPTIN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CORTICOTROPIN;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
HUMAN GROWTH HORMONE;
OCTREOTIDE;
RADIOPHARMACEUTICAL AGENT;
SOMATOMEDIN C;
SOMATOSTATIN;
SOMATOSTATIN RECEPTOR;
THYROTROPIN;
YTTRIUM;
ACROMEGALY;
ADENOMA;
CUSHING SYNDROME;
DRUG EFFECT;
FORECASTING;
HUMAN;
HYPOPHYSIS TUMOR;
MULTIMODALITY CANCER THERAPY;
PHYSIOLOGY;
PROLACTINOMA;
REVIEW;
SECRETION;
TREATMENT OUTCOME;
ACROMEGALY;
ADENOMA;
ADRENOCORTICOTROPIC HORMONE;
ANTINEOPLASTIC AGENTS, HORMONAL;
COMBINED MODALITY THERAPY;
CUSHING SYNDROME;
FORECASTING;
HUMAN GROWTH HORMONE;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
OCTREOTIDE;
PEPTIDES, CYCLIC;
PITUITARY NEOPLASMS;
PROLACTINOMA;
RADIOPHARMACEUTICALS;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
THYROTROPIN;
TREATMENT OUTCOME;
YTTRIUM RADIOISOTOPES;
|
EID: 0037974611
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (79)
|